The human IgE network

IgE and its receptors are believed to have evolved as a mechanism to protect mammals against parasites. But other and intrinsically innocuous antigens can subvert this system to provoke an allergic response. For human populations in industrialized countries, allergy and asthma now represent a far greater threat than parasitic infection, and the main impetus for current studies of the IgE system is the hope of understanding and intervening in the aetiology of allergic diseases.

[1]  D. Tuveson,et al.  Intersection of the complement and immune systems: a signal transduction complex of the B lymphocyte-containing complement receptor type 2 and CD19 , 1991, The Journal of experimental medicine.

[2]  L. Cantley,et al.  Oncogenes and signal transduction , 1991, Cell.

[3]  A. Aruffo,et al.  CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation. , 1992, Immunology today.

[4]  W. Weis,et al.  Structure of the calcium-dependent lectin domain from a rat mannose-binding protein determined by MAD phasing. , 1991, Science.

[5]  J. Yodoi,et al.  Fyn tyrosine kinase associated with Fc epsilon RII/CD23: possible multiple roles in lymphocyte activation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[6]  G. Guy,et al.  Triggering of B lymphocytes through CD23: epitope mapping and studies using antibody derivatives indicate an allosteric mechanism of signalling. , 1987, Immunology.

[7]  P. Debré,et al.  Expression, structure, and function of the CD23 antigen. , 1991, Advances in immunology.

[8]  A. Capron,et al.  Antibody-dependent cell-mediated cytotoxicity against parasites. , 1982, Progress in allergy.

[9]  Z. Eshhar,et al.  Fine specificity of the IgE interaction with the low and high affinity Fc receptor. , 1993, Journal of immunology.

[10]  Z. Eshhar,et al.  Relationships between epitopes on IgE recognized by defined monoclonal antibodies and by the FC epsilon receptor on basophils. , 1986, Journal of immunology.

[11]  F. Liu,et al.  S-type mammalian lectins in allergic inflammation. , 1993, Immunology today.

[12]  J. Ring,et al.  Induction of Fc epsilon R2/CD23 on human epidermal Langerhans cells by human recombinant interleukin 4 and gamma interferon , 1989, The Journal of experimental medicine.

[13]  D. Tuveson,et al.  The CD19 complex of B lymphocytes. Activation of phospholipase C by a protein tyrosine kinase-dependent pathway that can be enhanced by the membrane IgM complex. , 1991, Journal of immunology.

[14]  F. Melchers,et al.  The action of human C3 in soluble or cross‐linked form with resting and activated murine B lymphocytes , 1985, European journal of immunology.

[15]  R. Stevens,et al.  Inhibition of B cell proliferation by antisense DNA to both α and β forms of FcϵR II , 1992 .

[16]  E. Kieff,et al.  Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell death , 1991, Cell.

[17]  R. Geha,et al.  Regulation of IgE synthesis in humans: a tale of two signals. , 1991, The Journal of allergy and clinical immunology.

[18]  D. Tuveson,et al.  CD19 of B cells as a surrogate kinase insert region to bind phosphatidylinositol 3-kinase. , 1993, Science.

[19]  D. Dunne,et al.  Human immunity to Schistosoma mansoni: observations on mechanisms, and implications for control. , 1992, Immunological investigations.

[20]  M. Hulett,et al.  Chimeric Fc receptors identify immunoglobulin‐binding regions in human FcγRII and FcϵRI , 1993 .

[21]  M. Holder,et al.  A subset of anti‐CD21 antibodies promote the rescue of germinal center B cells from apoptosis , 1993, European journal of immunology.

[22]  D. Conrad,et al.  The murine lymphocyte receptor for IgE. IV. The mechanism of ligand-specific receptor upregulation on B cells. , 1987, Journal of immunology.

[23]  E. Padlan,et al.  A model of the Fc of immunoglobulin E. , 1985, Molecular immunology.

[24]  David I. Stuart,et al.  Crystal structure at 2.8 Å resolution of a soluble form of the cell adhesion molecule CD2 , 1992, Nature.

[25]  M. Hulett,et al.  Identification of the Immunoglobulin Binding Regions (IBR) of FcγRII and FcɛRI , 1992 .

[26]  A. Capron,et al.  Schistosomiasis: from effector and regulation mechanisms in rodents to vaccine strategies in humans. , 1992, Immunological investigations.

[27]  A. Kazlauskas,et al.  The B cell antigen receptor complex: association of Ig-alpha and Ig-beta with distinct cytoplasmic effectors. , 1992, Science.

[28]  H. Metzger.  The Receptor with High Affinity for IgE , 1992, Ciba Foundation symposium.

[29]  D. Kraft,et al.  Inhibition of allergic reactions with monoclonal antibody to the high affinity IgE receptor. , 1988, Journal of immunology.

[30]  S. Fournier,et al.  The Low‐Affinity Receptor for IgE , 1992, Immunological reviews.

[31]  B. Erlanger.  Why cyclosporin is an effective drug. , 1993, Immunology today.

[32]  D. Stanworth,et al.  Allergy treatment with a peptide vaccine , 1990, The Lancet.

[33]  W. Paul,et al.  Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. Conrad,et al.  The oligomeric nature of the murine Fc epsilon RII/CD23. Implications for function. , 1993, Journal of immunology.

[35]  J. Banchereau,et al.  Cross-linking of CD23 antigen by its natural ligand (IgE) or by anti-CD23 antibody prevents B lymphocyte proliferation and differentiation. , 1991, Journal of immunology.

[36]  A. Saxon,et al.  Binding the low affinity Fc epsilon R on B cells suppresses ongoing human IgE synthesis. , 1989, Journal of immunology.

[37]  H. Kikutani,et al.  Two forms of the low-affinity Fc receptor for IgE differentially mediate endocytosis and phagocytosis: identification of the critical cytoplasmic domains. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[38]  E. Padlan,et al.  The nature and importance of the inter‐ε chain disulfide bonds in human IgE , 1991, European journal of immunology.

[39]  J. Kinet,et al.  The high-affinity receptor for immunoglobulin E: a target for therapy of allergic diseases. , 1991, International archives of allergy and applied immunology.

[40]  C. Ra,et al.  Soluble human high-affinity receptor for IgE abrogates the IgE-mediated allergic reaction. , 1993, International immunology.

[41]  I. Maclennan,et al.  Recombinant 25‐kDa CD23 and interleukin 1α promote the survival of germinal center B cells: evidence for bifurcation in the development of centrocytes rescued from apoptosis , 1991, European journal of immunology.

[42]  B. Bettler,et al.  Immunoglobulin E-binding site in Fc epsilon receptor (Fc epsilon RII/CD23) identified by homolog-scanning mutagenesis. , 1992, The Journal of biological chemistry.

[43]  D. Katz,et al.  The binding of IgE to murine Fc epsilon RII is calcium-dependent but not inhibited by carbohydrate. , 1990, Journal of immunology.

[44]  B. Sugden.  An intricate route to immortality , 1989, Cell.

[45]  K. Rajewsky,et al.  Generation and analysis of interleukin-4 deficient mice. , 1991, Science.

[46]  R. Owens,et al.  Structural basis of the IgE-FcɛRI interaction , 1993 .

[47]  E. Rieber,et al.  IgE‐dependent antigen focusing by human B lymphocytes is mediated by the low‐affinity receptor for IgE , 1990, European journal of immunology.

[48]  J. Kochan,et al.  High affinity human IgE receptor (Fc epsilon RI). Analysis of functional domains of the alpha-subunit with monoclonal antibodies. , 1991, The Journal of biological chemistry.

[49]  F. Finkelman,et al.  Regulation of murine in vivo IgG and IgE responses by a monoclonal anti-IL-4 receptor antibody. , 1991, International immunology.

[50]  B. Bettler,et al.  Native and recombinant soluble CD23 fragments with IgE suppressive activity. , 1992, Immunology.

[51]  Wayne A. Hendrickson,et al.  Structure of a C-type mannose-binding protein complexed with an oligosaccharide , 1992, Nature.

[52]  B. Myones,et al.  Structural requirements for C3d,g/Epstein-Barr virus receptor (CR2/CD21) ligand binding, internalization, and viral infection. , 1990, The Journal of biological chemistry.

[53]  A. Capron,et al.  IgE receptor on human eosinophils (FcERII). Comparison with B cell CD23 and association with an adhesion molecule. , 1989, Journal of immunology.

[54]  M. W. Robertson,et al.  Phage and Escherichia coli expression of the human high affinity immunoglobulin E receptor alpha-subunit ectodomain. Domain localization of the IgE-binding site. , 1993, The Journal of biological chemistry.

[55]  I. Campbell,et al.  Three-dimensional structure of a complement control protein module in solution. , 1991, Journal of molecular biology.

[56]  J. Bolen,et al.  Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases , 1992, Nature.

[57]  A. Capron,et al.  Human neutrophils express immunoglobulin E (IgE)-binding proteins (Mac- 2/epsilon BP) of the S-type lectin family: role in IgE-dependent activation , 1993, The Journal of experimental medicine.

[58]  B. Erlanger.  Do we know the site of action of cyclosporin? , 1992, Immunology today.

[59]  J. Brostoff,et al.  Specific inhibition of IgE antibody production by an antisense oligodeoxynucleotide oligomer (Oligostick). , 1992, Immunology.

[60]  E. Padlan,et al.  The B-cell binding site on human immunoglobulin E , 1988, Nature.

[61]  A. Gilfillan,et al.  Purification and characterization of human recombinant IgE-Fc fragments that bind to the human high affinity IgE receptor. , 1993, The Journal of biological chemistry.

[62]  K. Ishizaka,et al.  Identification of gamma-E-antibodies as a carrier of reaginic activity. , 1967, Journal of immunology.

[63]  P. Debré,et al.  Cytokine effects of CD23 are mediated by an epitope distinct from the IgE binding site. , 1992, The EMBO journal.

[64]  Kinetics of ligand binding to the type 1 Fc epsilon receptor on mast cells. , 1991, Biochemistry.

[65]  H. Bazin,et al.  Inhibition of an in vivo antigen-specific IgE response by antibodies to CD23. , 1993, Science.

[66]  P. Benfey,et al.  Human and rat mast cell high-affinity immunoglobulin E receptors: characterization of putative alpha-chain gene products. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[67]  A. Beavil,et al.  Alpha-helical coiled-coil stalks in the low-affinity receptor for IgE (Fc epsilon RII/CD23) and related C-type lectins. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[68]  John D Lambris,et al.  Evidence for multiple sites of interaction in C3 for complement receptor type 2 (C3d/EBV receptor, CD21) , 1991, European journal of immunology.

[69]  J. Hanifin,et al.  Differential inhibitor effects on cyclic adenosine monophosphate-phosphodiesterase isoforms in atopic and normal leukocytes. , 1993, The Journal of laboratory and clinical medicine.

[70]  J. Cambier,et al.  Membrane immunoglobulin and its accomplices: new lessons from an old receptor 1 , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[71]  A. Capron,et al.  From parasites to allergy: a second receptor for IgE. , 1986, Immunology today.

[72]  D. Fearon,et al.  Mapping of the Epstein-Barr virus and C3dg binding sites to a common domain on complement receptor type 2 , 1989, The Journal of experimental medicine.

[73]  B. Helm,et al.  Human IgE mediates stimulus secretion coupling in rat basophilic leukemia cells transfected with the α chain of the human high‐affinity receptor , 1993 .

[74]  M. Spiess,et al.  The asialoglycoprotein receptor: a model for endocytic transport receptors. , 1990, Biochemistry.

[75]  B. Baird,et al.  Conformations of IgE bound to its receptor Fc epsilon RI and in solution. , 1991, Biochemistry.

[76]  A. Gilfillan,et al.  Conservation of signal transduction mechanisms via the human Fc epsilon RI alpha after transfection into a rat mast cell line, RBL 2H3. , 1992, Journal of immunology.

[77]  H. Kikutani,et al.  Molecular genetics and biology of two different species of FcεRII , 1990 .

[78]  J. Bonnefoy,et al.  CD21 expressed on basophilic cells is involved in histamine release triggered by CD23 and anti‐CD21 antibodies , 1993, European journal of immunology.

[79]  G. Nemerow,et al.  Hydrodynamic, electron microscopic, and ligand-binding analysis of the Epstein-Barr virus/C3dg receptor (CR2). , 1989, The Journal of biological chemistry.

[80]  Timothy A. Springer,et al.  Adhesion receptors of the immune system , 1990, Nature.

[81]  D. Fearon,et al.  Suppression of the immune response by a soluble complement receptor of B lymphocytes. , 1991, Science.

[82]  C. Hopkins.  Selective membrane protein trafficking: vectorial flow and filter. , 1992, Trends in biochemical sciences.

[83]  J. Bonnefoy,et al.  Demonstration of a second ligand for the low affinity receptor for immunoglobulin E (CD23) using recombinant CD23 reconstituted into fluorescent liposomes , 1992, The Journal of experimental medicine.

[84]  J. Bonnefoy,et al.  CD21 is a ligand for CD23 and regulates IgE production , 1992, Nature.

[85]  I. Maclennan,et al.  Germinal center cells express bcl‐2 protein after activation by signals which prevent their entry into apoptosis , 1991, European journal of immunology.

[86]  R. Frade,et al.  EBV/C3d receptor (CR2) interacts by its intracytoplasmic carboxy-terminal domain and two distinct binding sites with the p53 anti-oncoprotein and the p68 calcium-binding protein. , 1992, Journal of immunology.

[87]  J. Kinet,et al.  Characterization of truncated alpha chain products from human, rat, and mouse high affinity receptor for immunoglobulin E. , 1991, The Journal of biological chemistry.

[88]  L. Presta,et al.  Humanization of an antibody directed against IgE. , 1993, Journal of immunology.

[89]  P. Barnes.  Biochemistry of asthma. , 1991, Trends in biochemical sciences.

[90]  D. Fearon,et al.  CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. , 1992, Science.

[91]  J. Kochan,et al.  Identification of sites on the human Fc epsilon RI alpha subunit which are involved in binding human and rat IgE. , 1993, The Journal of biological chemistry.

[92]  A. F. Williams,et al.  The immunoglobulin superfamily--domains for cell surface recognition. , 1988, Annual review of immunology.

[93]  B. Wüthrich.  Epidemiology of the allergic diseases: are they really on the increase? , 1989, International archives of allergy and applied immunology.

[94]  K. Kishi,et al.  Induction of human IgE synthesis in B cells by mast cells and basophils , 1993, Nature.

[95]  T. Kurosaki,et al.  The beta subunit of the Fc epsilon RI is associated with the Fc gamma RIII on mast cells , 1992, The Journal of experimental medicine.

[96]  D. Födinger,et al.  Epidermal Langerhans cells from normal human skin bind monomeric IgE via Fc epsilon RI , 1992, The Journal of experimental medicine.

[97]  D. Fearon.  The CD19-CR2-TAPA-1 complex, CD45 and signaling by the antigen receptor of B lymphocytes. , 1993, Current opinion in immunology.

[98]  E. Kieff,et al.  Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element , 1991, Journal of virology.